Reuters logo
6 months ago
BRIEF-Ligand Pharmaceuticals says retrophin announced update on regulatory pathway for late-stage product candidate sparsentan
March 3, 2017 / 2:17 PM / 6 months ago

BRIEF-Ligand Pharmaceuticals says retrophin announced update on regulatory pathway for late-stage product candidate sparsentan

March 3 (Reuters) - Ligand Pharmaceuticals Inc

* Ligand Pharmaceuticals says on March 1 retrophin announced update on regulatory pathway for late-stage product candidate sparsentan - sec filing

* Ligand Pharmaceuticals Inc says update includes plans to initiate a phase 3 clinical trial in second half of 2017 - SEC filing Source text for Eikon: (bit.ly/2mTqDXs) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below